Reference
Vaccaro V, et al. Activity and safety of bevacizumab plus fotemustine for recurrent malignant gliomas. BioMed Research International 2014: 2014. Available from: URL: http://doi.org/10.1155/2014/351252 - Italy
Rights and permissions
About this article
Cite this article
Bevacizumab/fotemustine. Reactions Weekly 1509, 10 (2014). https://doi.org/10.1007/s40278-014-1810-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-1810-9